Budi Oetomo Narendra 
Billy Candra 
Lina carolina 
Hendra Lukman 
Gilang Cahya TERT Expression and Clinical Outcome in Pulmonary Carcinoids
A groundbreaking study by researchers at the University Hospital Cologne and the University of Cologne...
CD74 Protein Emerges as Key Predictor for Immunotherapy Response in Bowel Cancer, Promising Broader Patient Access
Researchers at the Francis Crick Institute and Barts Cancer Institute, Queen Mary University of London,...
Setbacks Emerge for Pioneering CAR-T Therapies in Autoimmune Diseases as Clinical Trials Face Safety Pauses
admin The promising frontier of harnessing powerful CAR-T cell therapies, long lauded for their transformative impact...
Clogged Brain Drainage System Identified as Early Warning Signal for Alzheimer’s Disease in Groundbreaking NTU Singapore Study
Gabriel Paijo In a significant advancement for neurodegenerative research, scientists from Nanyang Technological University, Singapore (NTU Singapore)...
New Research Suggests Vitamin D2 Supplements May Undermine the Body’s More Potent Vitamin D3 Levels
A groundbreaking meta-analysis conducted by researchers at the University of Surrey, John Innes Centre, and...
Breakthrough Engineering of Human Cell Lines Reveals Genome Resilience and Potential for Advanced Disease Research
George Ongkojoyo In a landmark achievement for the field of synthetic biology and genomics, an international consortium...
ORACLE Test Predicts Lung Cancer Survival Better Than Current Methods, Paving Way for Precision Treatment
Researchers at the Francis Crick Institute, the UCL Cancer Institute, and UCLH have unveiled groundbreaking...
Unlocking Coffee’s Health Secrets: Texas A&M Study Reveals Key Mechanism Through NR4A1 Receptor
Coffee has long been celebrated globally, not just for its invigorating properties but also for...
ESC Congress Unveils Pivotal Cardiovascular Trial Data, Reshaping Treatment Paradigms and Market Dynamics
The annual congress of the European Society of Cardiology (ESC), a preeminent global event in...
Breakthrough Monoclonal Antibody Targeting SFRP2 Protein Offers New Hope for Combating Triple-Negative Breast Cancer and Treatment Resistance
Triple-negative breast cancer (TNBC) remains one of the most formidable challenges in modern oncology, characterized...
